EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 4, 2020
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2020.0087?guestAccessKey=ff1b2f13-2ae4-40e5-b623-2e49a698abff&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030420
What The Study Did: Researchers examined associations between two of the most common weight-loss surgeries on type 2 diabetes outcomes by comparing diabetes remission and relapse rates, glycemic control and weight loss after five years among 9,700 adults with type 2 diabetes who had Roux-en-Y gastric bypass or sleeve gastrectomy.
Authors: Kathleen McTigue, M.D., of the University of Pittsburgh, is the corresponding author.
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.